Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Uterine Neoplasms 1Uterine Hemorrhage 1Uterine Diseases 1Postoperative Nausea and Vomiting 1Postoperative Complications 1Pancreatic Adenocarcinoma 1Pain, Postoperative 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Liver Neoplasms 1Leiomyoma 1Hypotension 1Cognitive Dysfunction 1Chronic Pain 1Breast Carcinoma In Situ 1Agnosia 1Acute Pain 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Anesthesia, General × 1 year × Clear all
NCT07395375 2026-02-09

NIVA-TSLR

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
1,600 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡